{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:15:37Z","timestamp":1791249337592,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Technology Department of Sichuan Province project","award":["NO.23ZDYF2116"],"award-info":[{"award-number":["NO.23ZDYF2116"]}]},{"name":"the Science and Technology Department of Sichuan Province project","award":["NO.23ZDYF2116"],"award-info":[{"award-number":["NO.23ZDYF2116"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["No.2021YFC2501601"],"award-info":[{"award-number":["No.2021YFC2501601"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04236-5","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:05:24Z","timestamp":1747645524000},"page":"603-613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["CXCR4-directed PET with 68Ga-pentixafor versus adrenal vein sampling for the diagnosis of unilateral primary aldosteronism"],"prefix":"10.1007","volume":"89","author":[{"given":"Lu","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"11","key":"4236_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","volume":"18","author":"AF Turcu","year":"2022","unstructured":"A.F. Turcu, J. Yang, A. Vaidya, Primary aldosteronism - a multidimensional syndrome. Nat Rev. Endocrinol. 18(11), 665\u2013682 (2022). https:\/\/doi.org\/10.1038\/s41574-022-00730-2.","journal-title":"Nat Rev. Endocrinol."},{"issue":"9","key":"4236_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"T.A. Williams, J. Lenders, P. Mulatero, J. Burrello, M. Rottenkolber, C. Adolf, F. Satoh, L. Amar, M. Quinkler, J. Deinum, F. Beuschlein, K.K. Kitamoto, U. Pham, R. Morimoto, H. Umakoshi, A. Prejbisz, T. Kocjan, M. Naruse, M. Stowasser, T. Nishikawa, W.F. Young Jr, C.E. Gomez-Sanchez, J.W. Funder, M. Reincke, Primary Aldosteronism Surgery Outcome (PASO), Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 5(9), 689\u2013699 (2017). https:\/\/doi.org\/10.1016\/S2213-8587(17)30135-3.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"4236_CR3","doi-asserted-by":"publisher","first-page":"e1280","DOI":"10.1210\/clinem\/dgad654","volume":"109","author":"S Samnani","year":"2024","unstructured":"S. Samnani, I. Cenzer, G.A. Kline, S.J. Lee, G.L. Hundemer, C. McClurg, J.L. Pasieka, W.J. Boscardin, P.E. Ronksley, A.A. Leung, Time to benefit of surgery vs targeted medical therapy for patients with primary aldosteronism: a meta-analysis. J Clin. Endocrinol. Metab. 109(3), e1280\u2013e1289 (2024). https:\/\/doi.org\/10.1210\/clinem\/dgad654.","journal-title":"J Clin. Endocrinol. Metab."},{"issue":"10","key":"4236_CR4","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"P. Mulatero, S. Monticone, J. Deinum, L. Amar, A. Prejbisz, M.C. Zennaro, F. Beuschlein, G.P. Rossi, T. Nishikawa, A. Morganti, T.M. Seccia, Y.H. Lin, F. Fallo, J. Widimsky, Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens. 38(10), 1919\u20131928 (2020). https:\/\/doi.org\/10.1097\/HJH.0000000000002510.","journal-title":"J Hypertens."},{"issue":"5","key":"4236_CR5","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr, The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4061.","journal-title":"J Clin. Endocrinol. Metab."},{"issue":"4","key":"4236_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","volume":"69","author":"M Naruse","year":"2022","unstructured":"M. Naruse, T. Katabami, H. Shibata, M. Sone, K. Takahashi, A. Tanabe, S. Izawa, T. Ichijo, M. Otsuki, M. Omura, Y. Ogawa, Y. Oki, I. Kurihara, H. Kobayashi, R. Sakamoto, F. Satoh, Y. Takeda, T. Tanaka, K. Tamura, M. Tsuiki, S. Hashimoto, T. Hasegawa, T. Yoshimoto, T. Yoneda, K. Yamamoto, H. Rakugi, N. Wada, A. Saiki, Y. Ohno, T. Haze, Japan endocrine society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 69(4), 327\u2013359 (2022). https:\/\/doi.org\/10.1507\/endocrj.EJ21-0508.","journal-title":"Endocr J."},{"issue":"2","key":"4236_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"B. Heinze, C.T. Fuss, P. Mulatero, F. Beuschlein, M. Reincke, M. Mustafa, A. Schirbel, T. Deutschbein, T.A. Williams, Y. Rhayem, M. Quinkler, N. Rayes, S. Monticone, V. Wild, C.E. Gomez-Sanchez, A.C. Reis, S. Petersenn, H.J. Wester, S. Kropf, M. Fassnacht, K. Lang, K. Herrmann, A.K. Buck, C. Bluemel, S. Hahner, Targeting CXCR4 (CXC chemokine receptor Type 4) for molecular imaging of aldosterone-producing adenoma. Hypertension 71(2), 317\u2013325 (2018). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09975.","journal-title":"Hypertension"},{"issue":"2","key":"4236_CR8","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00330-022-09058-x","volume":"33","author":"Y Gao","year":"2023","unstructured":"Y. Gao, J. Ding, Y. Cui, T. Li, H. Sun, D. Zhao, Y. Zhang, L. Huo, A. Tong, Functional nodules in primary aldosteronism: identification of CXCR4 expression with (68)Ga-pentixafor PET\/CT. Eur Radio. 33(2), 996\u20131003 (2023). https:\/\/doi.org\/10.1007\/s00330-022-09058-x.","journal-title":"Eur Radio."},{"issue":"2","key":"4236_CR9","doi-asserted-by":"publisher","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","volume":"6","author":"J Hu","year":"2023","unstructured":"J. Hu, T. Xu, H. Shen, Y. Song, J. Yang, A. Zhang, H. Ding, N. Xing, Z. Li, L. Qiu, L. Ma, Y. Yang, Z. Feng, Z. Du, W. He, Y. Sun, J. Cai, Q. Li, Y. Chen, S. Yang, Chongqing Primary Aldosteronism Study (CONPASS) G., Accuracy of gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism. JAMA Netw. Open 6(2), e2255609 (2023). https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55609.","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"4236_CR10","first-page":"241","volume":"31","author":"T Jia","year":"2023","unstructured":"T. Jia, C. Tao, T. Lu, X. Jing, X. Chen-Xiao, H. Lu, T. Hao-Ming, R. Yan, Suitable cutoff value of aldosterone to renin concentration ratio measured by chemiluminescence for screening primary aldosteronism among hypertensive population in sichuan. Chin J. Hypertens. 31(3), 241\u2013246 (2023).","journal-title":"Chin J. Hypertens."},{"issue":"4","key":"4236_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.eprac.2020.10.016","volume":"27","author":"B Liu","year":"2021","unstructured":"B. Liu, J. Hu, Y. Song, W. He, Q. Cheng, Z. Wang, Z. Feng, Z. Du, Z. Xu, J. Yang, Q. Li, S. Yang, Chongqing Primary Aldosteronism Study (CONPASS) G., Seated saline suppression test is comparable with captopril challenge test for the diagnosis of primary aldosteronism: a prospective study. Endocr Pr. 27(4), 326\u2013333 (2021). https:\/\/doi.org\/10.1016\/j.eprac.2020.10.016.","journal-title":"Endocr Pr."},{"issue":"7-08","key":"4236_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1055\/a-2106-4663","volume":"131","author":"N Younes","year":"2023","unstructured":"N. Younes, S. Larose, I. Bourdeau, E. Therasse, A. Lacroix, Role of adrenal vein sampling in guiding surgical decision in primary aldosteronism. Exp Clin. Endocrinol. Diabetes 131(7-08), 418\u2013434 (2023). https:\/\/doi.org\/10.1055\/a-2106-4663.","journal-title":"Exp Clin. Endocrinol. Diabetes"},{"issue":"6","key":"4236_CR13","first-page":"986","volume":"13","author":"Z Yushi","year":"2022","unstructured":"Z. Yushi, T. Anli, H. Li, Consensus on clinical application of the CXCR4-targeted imaging in the diagnosis of primary aldosteronism. Medical J. Peking. Union Med. Coll. Hospital 13(6), 986\u2013991 (2022).","journal-title":"Medical J. Peking. Union Med. Coll. Hospital"},{"issue":"1","key":"4236_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","volume":"106","author":"TA Williams","year":"2021","unstructured":"T.A. Williams, C.E. Gomez-Sanchez, W.E. Rainey, T.J. Giordano, A.K. Lam, A. Marker, O. Mete, Y. Yamazaki, M. Zerbini, F. Beuschlein, F. Satoh, J. Burrello, H. Schneider, J. Lenders, P. Mulatero, I. Castellano, T. Kn\u00f6sel, M. Papotti, W. Saeger, H. Sasano, M. Reincke, International histopathology consensus for unilateral primary aldosteronism. J Clin. Endocrinol. Metab. 106(1), 42\u201354 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgaa484.","journal-title":"J Clin. Endocrinol. Metab."},{"issue":"4","key":"4236_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00276-024-03331-y","volume":"46","author":"A Saadi","year":"2024","unstructured":"A. Saadi, M.A. Bedoui, S. Mokadem, S. Zaghbib, H. Boussaffa, M. Bellali, H. Ayed, A. Bouzouita, A. Derouiche, M. Allouche, M. Chakroun, R.B. Slama, Anatomy and anatomical variations of adrenal veins and its application to adrenal venous sampling. Surg Radio. Anat. 46(4), 543\u2013550 (2024). https:\/\/doi.org\/10.1007\/s00276-024-03331-y.","journal-title":"Surg Radio. Anat."},{"issue":"2","key":"4236_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12020-022-03122-8","volume":"78","author":"M Araujo-Castro","year":"2022","unstructured":"M. Araujo-Castro, M. Paja Fano, M. Gonz\u00e1lez Boillos, B. Pla Peris, E. Pascual-Corrales, A.M. Garc\u00eda Cano, P. Parra Ram\u00edrez, P.M. Rojas-Marcos, J.G. Ruiz-Sanchez, A. Vicente Delgado, E. G\u00f3mez Hoyos, R. Ferreira, I. Garc\u00eda Sanz, M. Recasens Sala, R. Barahona San Millan, M.J. Pic\u00f3n C\u00e9sar, P. D\u00edaz Guardiola, J.J. Garc\u00eda Gonz\u00e1lez, C.M. Perdomo, L. Manj\u00f3n Migu\u00e9lez, R. Garc\u00eda Centeno, J.C. Percovich, \u00c1 Rebollo Rom\u00e1n, P. Gracia Gimeno, C. Robles L\u00e1zaro, M. Morales-Ruiz, F.A. Hanzu, Adrenal venous sampling in primary aldosteronism: experience of a Spanish multicentric study (Results from the SPAIN-ALDO register). Endocrine 78(2), 363\u2013372 (2022). https:\/\/doi.org\/10.1007\/s12020-022-03122-8.","journal-title":"Endocrine"},{"issue":"9","key":"4236_CR17","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/02841851211034046","volume":"63","author":"S Kumasaka","year":"2022","unstructured":"S. Kumasaka, H. Tokue, Y. Tsushima, Difficulty factors of adrenal venous sampling based on patient characteristics and imaging findings. Acta Radio. 63(9), 1276\u20131282 (2022). https:\/\/doi.org\/10.1177\/02841851211034046.","journal-title":"Acta Radio."},{"issue":"5","key":"4236_CR18","first-page":"185","volume":"61","author":"N Furuta","year":"2015","unstructured":"N. Furuta, T. Naruoka, T. Igarashi, S. Bando, H. Yamada, T. Kimura, S. Egawa, Clinical evaluation of primary aldosteronism with subclinical Cushing\u2019s syndrome. Hinyokika Kiyo 61(5), 185\u2013190 (2015).","journal-title":"Hinyokika Kiyo"},{"issue":"8","key":"4236_CR19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3275\/8818","volume":"36","author":"K Fujimoto","year":"2013","unstructured":"K. Fujimoto, S. Honjo, H. Tatsuoka, Y. Hamamoto, Y. Kawasaki, A. Matsuoka, H. Ikeda, Y. Wada, H. Sasano, H. Koshiyama, Primary aldosteronism associated with subclinical Cushing syndrome. J Endocrinol. Invest 36(8), 564\u2013567 (2013). https:\/\/doi.org\/10.3275\/8818.","journal-title":"J Endocrinol. Invest"},{"issue":"20","key":"4236_CR20","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.3390\/jcm10204755","volume":"10","author":"G Ceolotto","year":"2021","unstructured":"G. Ceolotto, G. Antonelli, B. Caroccia, M. Battistel, G. Barbiero, M. Plebani, G.P. Rossi, Comparison of cortisol, androstenedione and metanephrines to assess selectivity and lateralization of adrenal vein sampling in primary aldosteronism. J Clin. Med 10(20), 4755 (2021). https:\/\/doi.org\/10.3390\/jcm10204755.","journal-title":"J Clin. Med"},{"issue":"1","key":"4236_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","volume":"29","author":"X Wu","year":"2023","unstructured":"X. Wu, R. Senanayake, E. Goodchild, W.A. Bashari, J. Salsbury, C.P. Cabrera, G. Argentesi, S.M. O'Toole, M. Matson, B. Koo, L. Parvanta, N. Hilliard, V. Kosmoliaptsis, A. Marker, D.M. Berney, W. Tan, R. Foo, C.A. Mein, E. Wozniak, E. Savage, A. Sahdev, N. Bird, K. Laycock, I. Boros, S. Hader, V. Warnes, D. Gillett, A. Dawnay, E. Adeyeye, A. Prete, A.E. Taylor, W. Arlt, A.N. Bhuva, F. Aigbirhio, C. Manisty, A. McIntosh, A. McConnachie, J.K. Cruickshank, H. Cheow, M. Gurnell, W.M. Drake, M.J. Brown, [(11)C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nat Med 29(1), 190\u2013202 (2023). https:\/\/doi.org\/10.1038\/s41591-022-02114-5.","journal-title":"Nat Med"},{"issue":"6","key":"4236_CR22","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/HJH.0000000000003132","volume":"40","author":"TH Puar","year":"2022","unstructured":"T.H. Puar, C.M. Khoo, C.J. Tan, A. Tong, M. Tan, A.E. Teo, K.S. Ng, K.M. Wong, A. Reilhac, J. O'Doherty, C.E. Gomez-Sanchez, P.C. Kek, S. Yee, A. Tan, M.B. Chuah, D. Lee, K.W. Wang, C.Q. Zheng, L. Shi, E.G. Robins, R. Foo, for the PA CURE investigators, 11C-metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial. J Hypertens. 40(6), 1179\u20131188 (2022). https:\/\/doi.org\/10.1097\/HJH.0000000000003132.","journal-title":"J Hypertens."},{"issue":"10","key":"4236_CR23","doi-asserted-by":"publisher","first-page":"dgaa379","DOI":"10.1210\/clinem\/dgaa379","volume":"105","author":"J Burrello","year":"2020","unstructured":"J. Burrello, A. Burrello, J. Pieroni, E. Sconfienza, V. Forestiero, P. Rabbia, C. Adolf, M. Reincke, F. Veglio, T.A. Williams, S. Monticone, P. Mulatero, Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism. J Clin. Endocrinol. Metab. 105(10), dgaa379 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa379.","journal-title":"J Clin. Endocrinol. Metab."},{"issue":"3","key":"4236_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11307-021-01664-3","volume":"24","author":"Z Chen","year":"2022","unstructured":"Z. Chen, A. Yang, J. Zhang, A. Chen, Y. Zhang, C. Huang, S. Chen, S. Yao, W. Miao, CXCR4-directed PET\/CT with [(68)Ga]Pentixafor in central nervous system lymphoma: a comparison with [(18)F]FDG PET\/CT. Mol Imaging Biol. 24(3), 416\u2013424 (2022). https:\/\/doi.org\/10.1007\/s11307-021-01664-3.","journal-title":"Mol Imaging Biol."},{"issue":"1","key":"4236_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2967\/jnumed.121.262206","volume":"63","author":"S Kraus","year":"2022","unstructured":"S. Kraus, A. Dierks, L. Rasche, O. Kertels, M. Kircher, A. Schirbel, J. Zovko, T. Steinbrunn, R. Tibes, H.J. Wester, A.K. Buck, H. Einsele, K.M. Kort\u00fcm, A. Rosenwald, C. Lapa, (68)Ga-pentixafor PET\/CT for detection of chemokine receptor CXCR4 expression in myeloproliferative neoplasms. J Nucl. Med 63(1), 96\u201399 (2022). https:\/\/doi.org\/10.2967\/jnumed.121.262206.","journal-title":"J Nucl. Med"},{"issue":"11","key":"4236_CR26","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1007\/s00259-018-4076-2","volume":"45","author":"T Derlin","year":"2018","unstructured":"T. Derlin, D.G. Sedding, J. Dutzmann, A. Haghikia, T. K\u00f6nig, L.C. Napp, C. Sch\u00fctze, N. Owsianski-Hille, H.J. Wester, S. Kropf, J.T. Thackeray, J.P. Bankstahl, L. Geworski, T.L. Ross, J. Bauersachs, F.M. Bengel, Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [(68)Ga]pentixafor PET\/CT. Eur J. Nucl. Med Mol. Imaging 45(11), 1934\u20131944 (2018). https:\/\/doi.org\/10.1007\/s00259-018-4076-2.","journal-title":"Eur J. Nucl. Med Mol. Imaging"},{"issue":"5","key":"4236_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2967\/jnumed.119.234484","volume":"61","author":"M Kircher","year":"2020","unstructured":"M. Kircher, J. Tran-Gia, L. Kemmer, X. Zhang, A. Schirbel, R.A. Werner, A.K. Buck, H.J. Wester, M. Hacker, C. Lapa, X. Li, Imaging inflammation in atherosclerosis with CXCR4-directed (68)Ga-pentixafor PET\/CT: correlation with (18)F-FDG PET\/CT. J Nucl. Med 61(5), 751\u2013756 (2020). https:\/\/doi.org\/10.2967\/jnumed.119.234484.","journal-title":"J Nucl. Med"},{"issue":"1","key":"4236_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1053\/j.semnuclmed.2023.09.002","volume":"54","author":"L Lindenberg","year":"2024","unstructured":"L. Lindenberg, M. Ahlman, F. Lin, E. Mena, P. Choyke, Advances in PET imaging of the CXCR4 receptor: [(68)Ga]Ga-PentixaFor. Semin Nucl. Med 54(1), 163\u2013170 (2024). https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.09.002.","journal-title":"Semin Nucl. Med"},{"key":"4236_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1291775","volume":"15","author":"X Yin","year":"2024","unstructured":"X. Yin, K. Ai, J. Luo, W. Liu, X. Ma, L. Zhou, X. Xiang, X. Su, Y. Wang, Y. Li, A comparison of the performance of (68)Ga-pentixafor PET\/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism. Front Endocrinol. (Lausanne) 15, 1291775 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1291775.","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"1","key":"4236_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/clinem\/dgad421","volume":"109","author":"Y Zheng","year":"2023","unstructured":"Y. Zheng, T. Long, N. Peng, M. Zhen, Q. Ye, Z. Zhang, Y. He, Z. Chen, Y. Gan, M. Luo, C. Li, Z. Liu, M. Guo, M. Wang, X. Luo, S. Hu, L. Liu, T. Jiang, The value of targeting CXCR4 with 68Ga-pentixafor PET\/CT for subtyping primary aldosteronism. J Clin. Endocrinol. Metab. 109(1), 171\u2013182 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgad421.","journal-title":"J Clin. Endocrinol. Metab."},{"issue":"2","key":"4236_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/ERC-21-0287","volume":"29","author":"JH Lin","year":"2022","unstructured":"J.H. Lin, K.Y. Peng, Y.P. Kuo, H. Liu, C.B. Tan, Y.F. Lin, H.W. Chiu, Y.H. Lin, Y.M. Chen, J.S. Chueh, V.C. Wu, Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism. Endocr Relat. Cancer 29(2), 59\u201369 (2022). https:\/\/doi.org\/10.1530\/ERC-21-0287.","journal-title":"Endocr Relat. Cancer"},{"key":"4236_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.663096","volume":"12","author":"H Wang","year":"2021","unstructured":"H. Wang, F. Wang, Y. Zhang, J. Wen, D. Dong, X. Chang, H. Sun, X. Ma, Y. Cui, S. Chen, L. Lu, W. Ren, A. Tong, Y. Li, Surgical outcomes of aldosterone-producing adenoma on the basis of the histopathological findings. Front Endocrinol. (Lausanne) 12, 663096 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.663096.","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"8","key":"4236_CR33","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/RLU.0000000000004244","volume":"47","author":"J Ding","year":"2022","unstructured":"J. Ding, A. Tong, M. Hacker, M. Feng, L. Huo, X. Li, Usefulness of 68 Ga-pentixafor PET\/CT on diagnosis and management of cushing syndrome. Clin Nucl. Med 47(8), 669\u2013676 (2022). https:\/\/doi.org\/10.1097\/RLU.0000000000004244.","journal-title":"Clin Nucl. Med"},{"issue":"3","key":"4236_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2967\/jnumed.121.261964","volume":"63","author":"J Ding","year":"2022","unstructured":"J. Ding, A. Tong, Y. Zhang, J. Wen, H. Zhang, M. Hacker, L. Huo, X. Li, Functional characterization of adrenocortical masses in nononcologic patients using (68)Ga-pentixafor. J Nucl. Med 63(3), 368\u2013375 (2022). https:\/\/doi.org\/10.2967\/jnumed.121.261964.","journal-title":"J Nucl. Med"},{"issue":"1","key":"4236_CR35","first-page":"27","volume":"52","author":"RE Brown","year":"2022","unstructured":"R.E. Brown, S. Zhang, X.I. Wang, Morphoproteomics identifies SIRT1, EZH2 and CXCR4 pathways in diffuse large B-cell lymphoma: therapeutic implications. Ann Clin. Lab Sci. 52(1), 27\u201332 (2022). 1550-8080 (Electronic); 0091-7370 (Linking).","journal-title":"Ann Clin. Lab Sci."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04236-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04236-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04236-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:11:31Z","timestamp":1753369891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04236-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4236"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04236-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures have been conducted as part of clinical routine care. Informed consent has been obtained from all subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of West China Hospital(Ethics number: 2019 Review No. 692).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}